Title : Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice - Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
Author(s) : Roche C , Besnier M , Cassel R , Harouki N , Coquerel D , Guerrot D , Nicol L , Loizon E , Remy-Jouet I , Morisseau C , Mulder P , Ouvrard-Pascaud A , Madec AM , Richard V , Bellien J |
Ref : American Journal of Physiology Heart Circ Physiol , 308 :H1020 , 2015 |
Abstract : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
ESTHER : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
PubMedSearch : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
PubMedID: 25724490 |
Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D, Nicol L, Loizon E, Remy-Jouet I, Morisseau C, Mulder P, Ouvrard-Pascaud A, Madec AM, Richard V, Bellien J (2015)
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice
American Journal of Physiology Heart Circ Physiol
308 :H1020
Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D, Nicol L, Loizon E, Remy-Jouet I, Morisseau C, Mulder P, Ouvrard-Pascaud A, Madec AM, Richard V, Bellien J (2015)
American Journal of Physiology Heart Circ Physiol
308 :H1020